The latest study on COPD Drugs Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global COPD Drugs Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of COPD Drugs and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV
COPD Drugs Market Analysis By Type Segment:
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
COPD Drugs Market Analysis By Application Segment:
Hospitals
Clinics
Others
COPD Drugs Market Analysis By Regions (Countries):
The COPD Drugs Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of COPD Drugs Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of COPD Drugs Market:
COPD Drugs market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the COPD Drugs Market status and future forecast.
To present the key COPD Drugs Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global COPD Drugs Market Size Growth Rate by Type (2016-2027)
1.4.2 Bronchodilators
1.4.3 PDE-4 Inhibitors
1.4.4 Steroids
1.4.5 Combination Therapies
1.4.6 Others
1.5 Market by Application
1.5.1 Global COPD Drugs Market Share by Application (2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 COPD Drugs Market Size
2.2 COPD Drugs Growth Trends by Regions
2.2.1 COPD Drugs Market Size by Regions (2016-2027)
2.2.2 COPD Drugs Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 COPD Drugs Market Size by Manufacturers
3.1.1 Global COPD Drugs Revenue by Manufacturers (2020)
3.1.2 Global COPD Drugs Revenue Market Share by Manufacturers (2020)
3.1.3 Global COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.2 COPD Drugs Key Players Head office and Area Served
3.3 Key Players COPD Drugs Product/Solution/Service
3.4 Date of Enter into COPD Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global COPD Drugs Market Size by Type (2016-2020)
4.2 Global COPD Drugs Market Size by Application (2016-2020)
5 United States
5.1 United States COPD Drugs Market Size (2016-2020)
5.2 COPD Drugs Key Players in United States
5.3 United States COPD Drugs Market Size by Type
5.4 United States COPD Drugs Market Size by Application
6 Europe
6.1 Europe COPD Drugs Market Size (2016-2020)
6.2 COPD Drugs Key Players in Europe
6.3 Europe COPD Drugs Market Size by Type
6.4 Europe COPD Drugs Market Size by Application
7 China
7.1 China COPD Drugs Market Size (2016-2020)
7.2 COPD Drugs Key Players in China
7.3 China COPD Drugs Market Size by Type
7.4 China COPD Drugs Market Size by Application
8 Japan
8.1 Japan COPD Drugs Market Size (2016-2020)
8.2 COPD Drugs Key Players in Japan
8.3 Japan COPD Drugs Market Size by Type
8.4 Japan COPD Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia COPD Drugs Market Size (2016-2020)
9.2 COPD Drugs Key Players in Southeast Asia
9.3 Southeast Asia COPD Drugs Market Size by Type
9.4 Southeast Asia COPD Drugs Market Size by Application
10 India
10.1 India COPD Drugs Market Size (2016-2020)
10.2 COPD Drugs Key Players in India
10.3 India COPD Drugs Market Size by Type
10.4 India COPD Drugs Market Size by Application
11 Central & South America
11.1 Central & South America COPD Drugs Market Size (2016-2020)
11.2 COPD Drugs Key Players in Central & South America
11.3 Central & South America COPD Drugs Market Size by Type
11.4 Central & South America COPD Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 COPD Drugs Introduction
12.1.4 Pfizer Revenue in COPD Drugs Business (2020)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 COPD Drugs Introduction
12.2.4 Novartis Revenue in COPD Drugs Business (2020)
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 COPD Drugs Introduction
12.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2020)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 COPD Drugs Introduction
12.4.4 Merck Revenue in COPD Drugs Business (2020)
12.4.5 Merck Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 COPD Drugs Introduction
12.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2020)
12.5.5 Abbott Laboratories Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 COPD Drugs Introduction
12.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2020)
12.6.5 Boehringer Ingelheim Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 COPD Drugs Introduction
12.7.4 AstraZeneca Revenue in COPD Drugs Business (2020)
12.7.5 AstraZeneca Recent Development
12.8 Roche Holding AG
12.8.1 Roche Holding AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 COPD Drugs Introduction
12.8.4 Roche Holding AG Revenue in COPD Drugs Business (2020)
12.8.5 Roche Holding AG Recent Development
12.9 Teva Pharmaceutical Industries
12.9.1 Teva Pharmaceutical Industries Company Details
12.9.2 Company Description and Business Overview
12.9.3 COPD Drugs Introduction
12.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2020)
12.9.5 Teva Pharmaceutical Industries Recent Development
12.10 Vectura Group
12.10.1 Vectura Group Company Details
12.10.2 Company Description and Business Overview
12.10.3 COPD Drugs Introduction
12.10.4 Vectura Group Revenue in COPD Drugs Business (2020)
12.10.5 Vectura Group Recent Development
12.11 Mylan NV
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table COPD Drugs Key Market Segments
Table Key Players COPD Drugs Covered
Table Global COPD Drugs Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global COPD Drugs Market Size Market Share by Type 2016-2027
Figure Bronchodilators Figures
Table Key Players of Bronchodilators
Figure PDE-4 Inhibitors Figures
Table Key Players of PDE-4 Inhibitors
Figure Steroids Figures
Table Key Players of Steroids
Figure Combination Therapies Figures
Table Key Players of Combination Therapies
Figure Others Figures
Table Key Players of Others
Table Global COPD Drugs Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure COPD Drugs Report Years Considered
Table Global COPD Drugs Market Size 2016-2027 (Million US$)
Figure Global COPD Drugs Market Size and Growth Rate 2016-2027 (Million US$)
Table Global COPD Drugs Market Size by Regions 2016-2027 (Million US$)
Table Global COPD Drugs Market Size by Regions 2016-2020 (Million US$)
Table Global COPD Drugs Market Share by Regions 2016-2020
Figure Global COPD Drugs Market Share by Regions 2016-2020
Figure Global COPD Drugs Market Share by Regions 2020
Table Market Top Trends
Table Global COPD Drugs Revenue by Manufacturers (2020) (Million US$)
Table Global COPD Drugs Market Share by Manufacturers (2020)
Figure Global COPD Drugs Market Share by Manufacturers in 2020
Table Global COPD Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players COPD Drugs Product/Solution/Service
Table Date of Enter into COPD Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table Global COPD Drugs Market Size Share by Type (2016-2020)
Figure Global COPD Drugs Market Size Market Share by Type (2016-2020)
Table Global COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table Global COPD Drugs Market Size Share by Application (2016-2020)
Figure Global COPD Drugs Market Size Market Share by Application (2016-2020)
Figure Global COPD Drugs Revenue Market Share by Application in 2020
Figure United States COPD Drugs Market Size 2016-2020 (Million US$)
Table United States Key Players COPD Drugs Revenue (2020) (Million US$)
Table United States Key Players COPD Drugs Market Share (2020)
Table United States COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table United States COPD Drugs Market Share by Type (2016-2020)
Table United States COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table United States COPD Drugs Market Share by Application (2016-2020)
Figure Europe COPD Drugs Market Size 2016-2020 (Million US$)
Table Europe Key Players COPD Drugs Revenue (2020) (Million US$)
Table Europe Key Players COPD Drugs Market Share (2020)
Table Europe COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table Europe COPD Drugs Market Share by Type (2016-2020)
Table Europe COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table Europe COPD Drugs Market Share by Application (2016-2020)
Figure China COPD Drugs Market Size 2016-2020 (Million US$)
Table China Key Players COPD Drugs Revenue (2020) (Million US$)
Table China Key Players COPD Drugs Market Share (2020)
Table China COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table China COPD Drugs Market Share by Type (2016-2020)
Table China COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table China COPD Drugs Market Share by Application (2016-2020)
Figure Japan COPD Drugs Market Size 2016-2020 (Million US$)
Table Japan Key Players COPD Drugs Revenue (2020) (Million US$)
Table Japan Key Players COPD Drugs Market Share (2020)
Table Japan COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table Japan COPD Drugs Market Share by Type (2016-2020)
Table Japan COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table Japan COPD Drugs Market Share by Application (2016-2020)
Figure Southeast Asia COPD Drugs Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players COPD Drugs Revenue (2020) (Million US$)
Table Southeast Asia Key Players COPD Drugs Market Share (2020)
Table Southeast Asia COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia COPD Drugs Market Share by Type (2016-2020)
Table Southeast Asia COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia COPD Drugs Market Share by Application (2016-2020)
Figure India COPD Drugs Market Size 2016-2020 (Million US$)
Table India Key Players COPD Drugs Revenue (2020) (Million US$)
Table India Key Players COPD Drugs Market Share (2020)
Table India COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table India COPD Drugs Market Share by Type (2016-2020)
Table India COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table India COPD Drugs Market Share by Application (2016-2020)
Figure Central & South America COPD Drugs Market Size 2016-2020 (Million US$)
Table Central & South America Key Players COPD Drugs Revenue (2020) (Million US$)
Table Central & South America Key Players COPD Drugs Market Share (2020)
Table Central & South America COPD Drugs Market Size by Type (2016-2020) (Million US$)
Table Central & South America COPD Drugs Market Share by Type (2016-2020)
Table Central & South America COPD Drugs Market Size by Application (2016-2020) (Million US$)
Table Central & South America COPD Drugs Market Share by Application (2016-2020)
Table Pfizer Company Details
Table Pfizer Revenue in COPD Drugs Business (2020) (Million US$)
Figure Pfizer Revenue Growth Rate in COPD Drugs Business (2020)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in COPD Drugs Business (2020)(Million US$)
Figure Novartis Revenue Growth Rate in COPD Drugs Business (2020)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in COPD Drugs Business (2020)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in COPD Drugs Business (2020)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in COPD Drugs Business (2020)(Million US$)
Figure Merck Revenue Growth Rate in COPD Drugs Business (2020)
Table Merck Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in COPD Drugs Business (2020)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in COPD Drugs Business (2020)
Table Abbott Laboratories Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in COPD Drugs Business (2020)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in COPD Drugs Business (2020)
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in COPD Drugs Business (2020)(Million US$)
Figure AstraZeneca Revenue Growth Rate in COPD Drugs Business (2020)
Table AstraZeneca Recent Development
Table Roche Holding AG Company Details
Table Roche Holding AG Revenue in COPD Drugs Business (2020)(Million US$)
Figure Roche Holding AG Revenue Growth Rate in COPD Drugs Business (2020)
Table Roche Holding AG Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2020)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in COPD Drugs Business (2020)
Table Teva Pharmaceutical Industries Recent Development
Table Vectura Group Company Details
Table Vectura Group Revenue in COPD Drugs Business (2020)(Million US$)
Figure Vectura Group Revenue Growth Rate in COPD Drugs Business (2020)
Table Vectura Group Recent Development
Table Mylan NV Company Details
Table Global COPD Drugs Market Size by Regions (Million US$) 2021-2027
Figure Global COPD Drugs Market Size Share by Regions (2021-2027)
Figure Global COPD Drugs Market Size Share by Regions in 2027
Figure United States COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Figure Europe COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Figure China COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Figure Japan COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Figure India COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America COPD Drugs Market Size Forecast (2021-2027)(Million USD)
Table Global COPD Drugs Market Size by Product (2021-2027) (Million US$)
Figure Global COPD Drugs Market Size by Product (2021-2027)
Figure Global COPD Drugs Market Size by Product in 2027
Table Global COPD Drugs Market Size by Application (2021-2027) (Million US$)
Figure Global COPD Drugs Market Size by Application (2021-2027)
Figure Global COPD Drugs Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources